SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: RealMuLan who wrote (2134)2/3/2009 8:18:27 PM
From: DewDiligence_on_SI  Read Replies (2) | Respond to of 2173
 
This news is less than it seems, IMO. MRNA (f.k.a. Nastech) has never been able to make its intranasal technology work for any drug, and they’ve tried it on many. MRK, PG, and NVO are among the various partners who have dumped MRNA’s programs when they didn’t meet expectations.